Eletriptan Hydrobromide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Eletriptan Hydrobromide
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Eletriptan Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 10 USDMF, 6 JDMF, 6 EU WC, 1 KDMF, 9 NDC API, 18 Listed Suppliers, $ API Reference Price

26 API Suppliers
10 USDMF
6 JDMF
6 EU WC
1 KDMF
9 NDC API
18 Listed Suppliers
$ API Reference Price

INTERMEDIATES

5 Intermediate Suppliers

5 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 20 FDA Orange Book, 65 Europe, 18 Canada, 2 Australia, 3 South Africa

108 FDF Dossiers
20 FDA Orange Book
65 Europe
18 Canada
2 Australia
3 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 20MG BASE
TABLET;ORAL - EQ 40MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 5 DKSH, 1 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 7 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 23 Controlled & Modified Release, 17 Direct Compression, 15 Disintegrants & Superdisintegrants, 15 Granulation, 14 Thickeners and Stabilizers, 13 Lubricants & Glidants, 12 Co-Processed Excipients, 8 Film Formers & Plasticizers, 7 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Solubilizers, 3 Topical, 3 Chewable & Orodispersible Aids, 3 Parenteral

50 Fillers, Diluents & Binders
49 Coating Systems & Additives
23 Controlled & Modified Release
17 Direct Compression
15 Disintegrants & Superdisintegrants
15 Granulation
14 Thickeners and Stabilizers
13 Lubricants & Glidants
12 Co-Processed Excipients
8 Film Formers & Plasticizers
7 API Stability Enhancers
5 Empty Capsules
5 Emulsifying Agents
5 Rheology Modifiers
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
3 Solubilizers
3 Topical
3 Chewable & Orodispersible Aids
3 Parenteral

DIGITAL CONTENT

12 NEWS #PharmaBuzz

12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 61 Finished Drug Prices, 5 Annual Reports

2 US Medicaid Prescriptions
61 Finished Drug Prices
5 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 6,095 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Pfizer Canada Inc.

filter Patent Reset all filters

6 All

01 22091562

02 22198599

03 22352392

filter Product Reset all filters

6 All

01 6Eletriptan Hydrobromide

filter Dosage Reset all filters

6 All

01 6Tablet

filter Exp Date Reset all filters

6 All

01 22011-10-08

02 22015-05-17

03 22019-11-01

Product Main Page

01

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-11-01

Date Granted : 2006-01-24

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2352392

Filing Date : 1999-11-01

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-11-01

Date Granted : 2006-01-24

Portfolio PDF

Product Web Link

Digital Content

02

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-11-01

Date Granted : 2006-01-24

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2352392

Filing Date : 1999-11-01

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-11-01

Date Granted : 2006-01-24

Portfolio PDF

Product Web Link

Digital Content

03

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-10-08

Date Granted : 2001-03-27

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2091562

Filing Date : 1991-10-08

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-10-08

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

04

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-05-17

Date Granted : 2000-06-06

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2198599

Filing Date : 1995-05-17

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-05-17

Date Granted : 2000-06-06

Portfolio PDF

Product Web Link

Digital Content

05

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-10-08

Date Granted : 2001-03-27

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2091562

Filing Date : 1991-10-08

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-10-08

Date Granted : 2001-03-27

Portfolio PDF

Product Web Link

Digital Content

06

Pfizer Canada Inc.

Eletriptan Hydrobromide

BioAsia

Not Confirmed

Pfizer Canada Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-05-17

Date Granted : 2000-06-06

Eletriptan Hydrobromide

Brand Name : RELPAX

Patent Number : 2198599

Filing Date : 1995-05-17

Strength per Unit : 40 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-05-17

Date Granted : 2000-06-06

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!